• Title of article

    Comorbidity of Diabetes and Covid-19 in 570 Positive Polymerase Chain Reaction Patients in Yazd-2019-2020

  • Author/Authors

    Ansari ، Kazem Yazd Stem Cells and Regenerative Medicine Institute, Nano-Biotech Foresight Company Biotechnology Campus , Mousavi ، Alireza Infectious Diseases Research Center - Shahid Sadoughi University of Medical Sciences , Cheraghipour ، Mohammad Islamic Azad University of Yazd , AkhoundiMeybodi ، Zohreh Infectious Diseases Research Center - Shahid Sadoughi University of Medical Sciences

  • From page
    138
  • To page
    144
  • Abstract
    Objective: Epidemiological evidence shows that the prevalence of patients with comorbidity of diabetes mellitus (DM), in Coronavirus disease 2019 (COVID-19) is remarkable and they have poor prognosis. We aimed to investigate the comorbidity of diabetes and covid-19 in positive Polymerase Chain Reaction people in Yazd. Materials and Methods: This retrospective cohort study included data of 570 COVID-19 positive patients, admitted to Shahid Sadoughi Hospital in Yazd, Iran, from February2019 to May 2020, including demographic data and clinical outcome of COVID-19. Study data were analyzed using SPSS software-22 and T-test, Chi-square and a binary logistic regression model were used for modeling. Results: Prevalence of COVID-19 patients with diabetes was 27% and the percentage of male patients was 62.6%. Additionally, duration of hospitalization significantly higher in diabetic patients (P= 0.004), need to invasive mechanical ventilation in diabetic patients was significantly higher than non-diabetic patients (P˂ 0.001) Conclusion: DM is one of the most important comorbidity with COVID-19 patients and this comorbidity affects the severity of the disease and the outcome of patients.
  • Keywords
    Diabetes mellitus , COVID , 19 , Comorbidity , Yazd
  • Journal title
    Iranian Journal of Diabetes and Obesity
  • Journal title
    Iranian Journal of Diabetes and Obesity
  • Record number

    2726999